Early detection and treatment of the vulnerable coronary plaque: Can we prevent acute coronary syndromes?

Michiel J. Bom, Dirk J. Van Der Heijden, Elvin Kedhi, Jan Van Der Heyden, Martijn Meuwissen, Paul Knaapen, Stefan A.J. Timmer, Niels Van Royen

Research output: Contribution to journalReview articleAcademicpeer-review

Abstract

Early identification and treatment of the vulnerable plaque, that is, a coronary artery lesion with a high likelihood of rupture leading to an acute coronary syndrome, have gained great interest in the cardiovascular research field. Postmortem studies have identified clear morphological characteristics associated with plaque rupture. Recent advances in invasive and noninvasive coronary imaging techniques have empowered the clinician to identify suspected vulnerable plaques in vivo and paved the way for the evaluation of therapeutic agents targeted at reducing plaque vulnerability. Local treatment of vulnerable plaques by percutaneous coronary intervention and systemic treatment with anti-inflammatory and low-density lipoprotein-lowering drugs are currently being investigated in large randomized clinical trials to assess their therapeutic potential for reducing adverse coronary events. Results from these studies may enable a more patient-tailored strategy for the treatment of coronary artery disease.

Original languageEnglish
Article numbere005973
JournalCirculation: Cardiovascular Imaging
Volume10
Issue number5
DOIs
Publication statusPublished - 1 May 2017

Cite this

Bom, Michiel J. ; Van Der Heijden, Dirk J. ; Kedhi, Elvin ; Van Der Heyden, Jan ; Meuwissen, Martijn ; Knaapen, Paul ; Timmer, Stefan A.J. ; Van Royen, Niels. / Early detection and treatment of the vulnerable coronary plaque : Can we prevent acute coronary syndromes?. In: Circulation: Cardiovascular Imaging. 2017 ; Vol. 10, No. 5.
@article{a0a5e7af21ba4f8986846fee285a6eb8,
title = "Early detection and treatment of the vulnerable coronary plaque: Can we prevent acute coronary syndromes?",
abstract = "Early identification and treatment of the vulnerable plaque, that is, a coronary artery lesion with a high likelihood of rupture leading to an acute coronary syndrome, have gained great interest in the cardiovascular research field. Postmortem studies have identified clear morphological characteristics associated with plaque rupture. Recent advances in invasive and noninvasive coronary imaging techniques have empowered the clinician to identify suspected vulnerable plaques in vivo and paved the way for the evaluation of therapeutic agents targeted at reducing plaque vulnerability. Local treatment of vulnerable plaques by percutaneous coronary intervention and systemic treatment with anti-inflammatory and low-density lipoprotein-lowering drugs are currently being investigated in large randomized clinical trials to assess their therapeutic potential for reducing adverse coronary events. Results from these studies may enable a more patient-tailored strategy for the treatment of coronary artery disease.",
keywords = "Acute coronary syndrome, Atherosclerosis, Computed tomography angiography, Coronary artery disease, Optical coherence, Tomography",
author = "Bom, {Michiel J.} and {Van Der Heijden}, {Dirk J.} and Elvin Kedhi and {Van Der Heyden}, Jan and Martijn Meuwissen and Paul Knaapen and Timmer, {Stefan A.J.} and {Van Royen}, Niels",
year = "2017",
month = "5",
day = "1",
doi = "10.1161/CIRCIMAGING.116.005973",
language = "English",
volume = "10",
journal = "Circulation.Cardiovascular Imaging",
issn = "1941-9651",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

Early detection and treatment of the vulnerable coronary plaque : Can we prevent acute coronary syndromes? / Bom, Michiel J.; Van Der Heijden, Dirk J.; Kedhi, Elvin; Van Der Heyden, Jan; Meuwissen, Martijn; Knaapen, Paul; Timmer, Stefan A.J.; Van Royen, Niels.

In: Circulation: Cardiovascular Imaging, Vol. 10, No. 5, e005973, 01.05.2017.

Research output: Contribution to journalReview articleAcademicpeer-review

TY - JOUR

T1 - Early detection and treatment of the vulnerable coronary plaque

T2 - Can we prevent acute coronary syndromes?

AU - Bom, Michiel J.

AU - Van Der Heijden, Dirk J.

AU - Kedhi, Elvin

AU - Van Der Heyden, Jan

AU - Meuwissen, Martijn

AU - Knaapen, Paul

AU - Timmer, Stefan A.J.

AU - Van Royen, Niels

PY - 2017/5/1

Y1 - 2017/5/1

N2 - Early identification and treatment of the vulnerable plaque, that is, a coronary artery lesion with a high likelihood of rupture leading to an acute coronary syndrome, have gained great interest in the cardiovascular research field. Postmortem studies have identified clear morphological characteristics associated with plaque rupture. Recent advances in invasive and noninvasive coronary imaging techniques have empowered the clinician to identify suspected vulnerable plaques in vivo and paved the way for the evaluation of therapeutic agents targeted at reducing plaque vulnerability. Local treatment of vulnerable plaques by percutaneous coronary intervention and systemic treatment with anti-inflammatory and low-density lipoprotein-lowering drugs are currently being investigated in large randomized clinical trials to assess their therapeutic potential for reducing adverse coronary events. Results from these studies may enable a more patient-tailored strategy for the treatment of coronary artery disease.

AB - Early identification and treatment of the vulnerable plaque, that is, a coronary artery lesion with a high likelihood of rupture leading to an acute coronary syndrome, have gained great interest in the cardiovascular research field. Postmortem studies have identified clear morphological characteristics associated with plaque rupture. Recent advances in invasive and noninvasive coronary imaging techniques have empowered the clinician to identify suspected vulnerable plaques in vivo and paved the way for the evaluation of therapeutic agents targeted at reducing plaque vulnerability. Local treatment of vulnerable plaques by percutaneous coronary intervention and systemic treatment with anti-inflammatory and low-density lipoprotein-lowering drugs are currently being investigated in large randomized clinical trials to assess their therapeutic potential for reducing adverse coronary events. Results from these studies may enable a more patient-tailored strategy for the treatment of coronary artery disease.

KW - Acute coronary syndrome

KW - Atherosclerosis

KW - Computed tomography angiography

KW - Coronary artery disease

KW - Optical coherence

KW - Tomography

UR - http://www.scopus.com/inward/record.url?scp=85019389241&partnerID=8YFLogxK

U2 - 10.1161/CIRCIMAGING.116.005973

DO - 10.1161/CIRCIMAGING.116.005973

M3 - Review article

VL - 10

JO - Circulation.Cardiovascular Imaging

JF - Circulation.Cardiovascular Imaging

SN - 1941-9651

IS - 5

M1 - e005973

ER -